The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Snodgres Jon since 2017.
This trader's CIK number is 1613498.
At the time of last reporting, Snodgres Jon was the Chief Financial Officer of Repligen Corp. (stock ticker symbol RGEN).
Also see all insider trading activities at Repligen Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | RGEN | 0 | $0 | 5,647 | $1,129,400 | 0 | $0 |
| 2022 | RGEN | 0 | $0 | 8,698 | $2,134,125 | 8,183 | $800,455 |
| 2021 | RGEN | 0 | $0 | 7,972 | $1,527,180 | 4,000 | $135,480 |
| 2020 | RGEN | 0 | $0 | 21,500 | $2,967,737 | 17,173 | $569,026 |
| 2019 | RGEN | 0 | $0 | 10,987 | $645,121 | 3,957 | $100,013 |
| 2018 | RGEN | 0 | $0 | 46,213 | $2,779,259 | 31,753 | $866,444 |
| 2017 | RGEN | 0 | $0 | 1,909 | $66,647 | 4,000 | $98,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-16 | RGEN | Sale | 5,647 | 200.00 | 1,129,400 |
| 2022-08-16 | RGEN | Option Ex | 4,017 | 150.84 | 605,924 |
| 2022-08-16 | RGEN | Sale | 6,698 | 252.93 | 1,694,125 |
| 2022-08-01 | RGEN | Sale | 2,000 | 220.00 | 440,000 |
| 2022-03-08 | RGEN | Option Ex | 4,166 | 46.70 | 194,531 |
| 2021-05-14 | RGEN | Sale | 470 | 172.60 | 81,122 |
| 2021-03-04 | RGEN | Sale | 3,545 | 193.15 | 684,716 |
| 2021-01-25 | RGEN | Option Ex | 4,000 | 33.87 | 135,480 |
| 2021-01-04 | RGEN | Sale | 3,957 | 192.40 | 761,342 |
| 2020-11-09 | RGEN | Sale | 705 | 194.69 | 137,256 |
| 2020-11-10 | RGEN | Sale | 3,086 | 193.00 | 595,598 |
| 2020-11-09 | RGEN | Option Ex | 1,893 | 59.52 | 112,671 |
| 2020-11-10 | RGEN | Option Ex | 3,086 | 32.40 | 99,986 |
| 2020-05-15 | RGEN | Sale | 660 | 140.43 | 92,683 |
| 2020-05-13 | RGEN | Sale | 15,394 | 129.53 | 1,993,954 |
| 2020-05-13 | RGEN | Option Ex | 12,194 | 29.23 | 356,369 |
| 2020-03-03 | RGEN | Sale | 610 | 88.18 | 53,789 |
| 2020-03-04 | RGEN | Sale | 1,045 | 90.39 | 94,457 |
| 2019-12-05 | RGEN | Option Ex | 3,957 | 25.27 | 100,013 |
| 2019-03-25 | RGEN | Sale | 6,467 | 58.75 | 379,936 |
| 2019-03-05 | RGEN | Sale | 2,645 | 58.52 | 154,785 |
| 2019-02-28 | RGEN | Sale | 1,875 | 58.88 | 110,400 |
| 2018-11-26 | RGEN | Option Ex | 31,753 | 27.29 | 866,444 |
| 2018-11-26 | RGEN | Sale | 31,753 | 63.49 | 2,015,902 |
| 2018-08-28 | RGEN | Sale | 14,460 | 52.79 | 763,357 |
| 2017-03-17 | RGEN | Sale | 1,909 | 34.91 | 66,647 |
| 2017-03-17 | RGEN | Option Ex | 4,000 | 24.50 | 98,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Snodgres Jon (Chief Financial Officer of Repligen Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.